Dr. Elise C. Kohn, National Cancer Institute, Bethesda
Guest Speaker
Dr. Kohn is a graduate of the University of Michigan Medical School where she also completed residency training in Internal Medicine; she came to the NCI for Medical Oncology training in the Medicine Branch. Dr. Kohn then joined the Laboratory of Pathology to investigate signal transduction molecular targets in invasion and angiogenesis, and ovarian cancer and maintained her clinical focus in the translational clinical studies of ovarian cancer. Recently, Dr. Kohn has been involved in the identification and characterization of two proteins involved in ovarian cancer and cellular stress. In parallel, her clinical work has evolved to include the newest proteomic technologies applied to early detection testing and validation of therapeutic targets in clinical trials. Dr. Kohn also applies the advanced proteomic applications to her laboratory studies of stress pathways, growth factor regulation, and angiogenesis
Dr. Kohn serves on numerous NIH and NCI committees, and is the newly elected Chair of the Integration Panel of the Department of Defense Ovarian Cancer Research Program. Dr. Kohn is a participating member and protocol investigator in the Gynecologic Oncology Group, judges the Fellows Award for Research Excellence competition yearly, and is the co-Chair of the Breast and Gynecologic Malignancies Faculty. She was recognized with the NCI Diversity Award and Mentor of Merit Award in 2007. Dr. Kohn was elected a Fellow of the American Association for the Advancement of Science.


